Severe COVID-19 Associated With Liver Injury in Patients Without Preexisting Liver Disease

被引:6
|
作者
Altaf, Abeer [1 ]
Abbas, Zaigham [1 ]
Mandviwalla, Haider A. [2 ]
Qadeer, Muhammad Ali [1 ]
Siyal, Mehreen [1 ]
Tariq, Mahnoor [2 ]
Ghafoor, Asmara [2 ]
Karamat, Muniba [2 ]
Shahid, Bushra [2 ]
Ali, Mahnoor [2 ]
机构
[1] Dr Ziauddin Hosp, Gastroenterol & Hepatol, Karachi, Pakistan
[2] Dr Ziauddin Hosp, Internal Med, Karachi, Pakistan
关键词
covid-19; liver function tests; ast (aspartate aminotransferase); severity of disease; liver injury;
D O I
10.7759/cureus.14705
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Coronavirus disease 2019 (COVID-19) is known to disturb liver function tests (LFTs). Not much literature is available regarding the effect of COVID-19 on LFTs in patients without preexisting liver disease. The study aimed to find the effect of COVID-19 in these patients. Methods: This was a single-center, observational study with 142 patients who were admitted with COVID-19 during three months. Seven patients were excluded due to the presence of chronic liver disease. Results: A total of 135 patients were included in the study aged between 18 and 95 years (mean 57.7 +/- 15.6); among them, 93 were males (68.9%). Hypertension was present in 74 patients (54.8%), and diabetes was present in 48 patients (35.6%). Fever was the chief complaint in 112 patients (83%), followed by dyspnea in 93 patients (68.9%) and cough in 79 patients (58.5%). Elevated aspartate aminotransferase (AST) was seen in 35 patients (26%), gamma-glutamyl transferase (GGT) in 43 patients (32%), alanine transaminase (ALT) in 18 patients (24%), alkaline phosphatase in 19 patients (14%), bilirubin in six patients (4%), and low albumin in 27 patients (20%). Severe COVID-19, when compared with mild to moderate disease, was associated with elevated AST > two-time upper limit normal (2ULN) (p = 0.002), GGT > 2ULN (0.026), and lower albumin (p = 0.020), higher systemic inflammatory response syndrome (SIRS) (0.045), raised procalcitonin (p = 0.045), higher ferritin (p = 0.005), lower pO2 (p = 0.044), and higher Sequential Organ Failure Assessment score (SOFA) (p = 0.002) pointing to the inflammatory response as cause of liver injury. Factors predicting mortality with COVID-19 were assessed, which showed that direct bilirubin (p = 0.001), low albumin (p = 0.013), tachypnea (0.002), and leukocytosis (<0.001) were independently associated with increased COVID-19-related mortality. Conclusion: Patients suffering from COVID-19 have evidence of liver injury, which appears to be secondary to an inflammatory response that correlates with the severity of COVID-19.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Clinical Course and Risk Factors for Liver Injury of Severe and Critical Patients with COVID-19
    Du, Chunjing
    Yang, Siyuan
    Li, Chuansheng
    Xiang, Pan
    Pu, Lin
    Liu, Jingyuan
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 7025 - 7035
  • [32] Risk factors in patients with COVID-19 developing severe liver injury during hospitalisation
    Zhan, Ke
    Liao, Shengtao
    Li, Jinfang
    Bai, Yang
    Lv, Lin
    Yu, Keqi
    Qiu, Liewang
    Li, Chuanfei
    Yuan, Guodan
    Zhang, An
    Mei, Zhechuan
    GUT, 2021, 70 (03) : 628 - +
  • [33] Liver Injury in Patients with Coronavirus Disease 2019 (COVID-19)-A Narrative Review
    Lykowska-Szuber, Liliana
    Wolodzko, Karolina
    Rychter, Anna Maria
    Szymczak-Tomczak, Aleksandra
    Krela-Kazmierczak, Iwona
    Dobrowolska, Agnieszka
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)
  • [34] Metabolic dysfunction associated fatty liver disease increases risk of severe Covid-19
    Sharma, Praveen
    Kumar, Ashish
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (05) : 825 - 827
  • [35] COVID-19 and liver disease
    Dufour, Jean-Francois
    Marjot, Thomas
    Becchetti, Chiara
    Tilg, Herbert
    GUT, 2022, 71 (11) : 2350 - 2362
  • [36] COVID-19 and liver disease
    Sun, Jian
    Aghemo, Alessio
    Forner, Alejandro
    Valenti, Luca
    LIVER INTERNATIONAL, 2020, 40 (06) : 1278 - 1281
  • [37] Liver Injury in Liver Transplant Patients With COVID-19: A Histopathologic Analysis Reply
    Krueger, Martin
    Robson, Simon C.
    Esch, Jan Schulte Am
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (07) : 1510 - 1510
  • [38] Liver Injury and Dysfunction Associated with COVID-19: a Review Article
    Yahia, Amar I. O.
    CLINICAL LABORATORY, 2022, 68 (01) : 1 - 7
  • [39] Liver injury in COVID-19: A minireview
    Hu, Wen-Shu
    Jiang, Fang-Ying
    Shu, Wen
    Zhao, Rong
    Cao, Ji-Min
    Wang, De-Ping
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (47) : 6716 - 6731
  • [40] The Impact of COVID-19 on Liver Injury
    Dawood, Reham M.
    Salum, Ghada Maher
    Abd El-Meguid, Mai
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2022, 363 (02): : 94 - 103